---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-037254"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2026-08-12T12:29:46+00:00"
generated_at: "2026-08-12T12:35:17.102114+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ENvue Medical signs $50M equity facility; amends Series H preferred to add $59M

## Summary
- Entered $50M committed equity facility; shares sold at 90% of 3-day VWAP.
- 40% of net proceeds to redeem Series X Preferred; remainder for working capital.
- Second Amendment raises Series H Additional Investment Rights to $59M stated value ($53.1M subscription).
- Investor commits to exercise at least $10M in 12 months post-shareholder approval, $833,333.33 monthly minimum.
- Exchange cap of 1,858,403 shares (19.99% of outstanding) unless shareholder approval.

## SEC filing metadata
- accession: 0001493152-26-037254
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2026-08-12T12:29:46+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315226037254/0001493152-26-037254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315226037254/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-037254
- JSON: https://secwatch.observer/filing/0001493152-26-037254.json
- Plain text: https://secwatch.observer/filing/0001493152-26-037254.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.